# BioXcel Therapeutics, Inc.: filings

BTAIQ · OTC · CIK 1720893 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/btaiq.md) · [Financials](/companies/btaiq/financials.md) · [Filings](/companies/btaiq/filings.md) · [Insiders](/companies/btaiq/insiders.md)

## Reports and events: 227 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 230, 8-K 174, 144 43, 3 35, 10-Q 26, 424B5 20, SC 13G/A 18, CORRESP 11, UPLOAD 9, 10-K 8, DEF 14A 8, EFFECT 7, S-8 7, 5 6, S-3 6, DEFA14A 5, SC 13G 5, SCHEDULE 13G 5, SCHEDULE 13G/A 5, PRE 14A 4, SC 13D/A 4, 4/A 3, DRSLTR 3, S-1/A 3, 144/A 2, 3/A 2, CT ORDER 2, DRS/A 2, RW 2, SC 13D 2, 10-K/A 1, 424B4 1, 424B7 1, 8-A12B 1, ARS 1, DEL AM 1, DRS 1, FWP 1, POS AM 1, POSASR 1, RW WD 1, S-1 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 17:15 ET | [8-K](/filings/0001104659-26-120737.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-120737 |
| 2026-09-01 | 07:01 ET | [8-K](/filings/0001104659-26-104106.md) | 2.03 New direct financial obligation; 3.01 Delisting notice | 0001104659-26-104106 |
| 2026-08-28 | 06:00 ET | [8-K](/filings/0001104659-26-102570.md) | 1.01 Entry into a material agreement; 1.03 Bankruptcy or receivership | 0001104659-26-102570 |
| 2026-08-25 | 07:15 ET | [8-K](/filings/0001104659-26-100532.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-100532 |
| 2026-08-24 | 07:00 ET | [8-K](/filings/0001104659-26-099900.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-099900 |
| 2026-08-13 | 16:31 ET | [10-Q](/filings/0001104659-26-095965.md) | Quarterly report, period 2026-06-30 | 0001104659-26-095965 |
| 2026-08-11 | 07:00 ET | [8-K](/filings/0001104659-26-093710.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-093710 |
| 2026-08-03 | 07:00 ET | [8-K](/filings/0001104659-26-089436.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-089436 |
| 2026-07-06 | 06:00 ET | [8-K](/filings/0001104659-26-080501.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-080501 |
| 2026-05-15 | 07:07 ET | [8-K](/filings/0001104659-26-061773.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-061773 |
| 2026-05-15 | 07:05 ET | [10-Q](/filings/0001104659-26-061769.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061769 |
| 2026-04-17 | 17:00 ET | [8-K](/filings/0001104659-26-044952.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-044952 |
| 2026-04-01 | 06:58 ET | [8-K](/filings/0001104659-26-038174.md) | 8.01 Other events | 0001104659-26-038174 |
| 2026-03-27 | 17:02 ET | [10-K](/filings/0001104659-26-036214.md) | Annual report, period 2025-12-31 | 0001104659-26-036214 |
| 2026-03-27 | 07:21 ET | [8-K](/filings/0001104659-26-035661.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-035661 |
| 2026-03-11 | 16:30 ET | [8-K](/filings/0001104659-26-026409.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-026409 |
| 2026-02-12 | 07:05 ET | [8-K](/filings/0001104659-26-013840.md) | 8.01 Other events | 0001104659-26-013840 |
| 2026-02-06 | 17:00 ET | [8-K](/filings/0001104659-26-011595.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-011595 |
| 2026-01-20 | 07:00 ET | [8-K](/filings/0001104659-26-004787.md) | 8.01 Other events | 0001104659-26-004787 |
| 2026-01-12 | 07:02 ET | [8-K](/filings/0001104659-26-002697.md) | 8.01 Other events | 0001104659-26-002697 |
| 2025-12-15 | 16:30 ET | [8-K](/filings/0001104659-25-121180.md) | 5.07 Shareholder vote results | 0001104659-25-121180 |
| 2025-11-12 | 17:00 ET | [DEF 14A](/filings/0001104659-25-110491.md) | Proxy statement, period 2025-12-12 | 0001104659-25-110491 |
| 2025-11-12 | 09:01 ET | [10-Q](/filings/0001104659-25-109880.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109880 |
| 2025-11-12 | 07:11 ET | [8-K](/filings/0001104659-25-109732.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109732 |
| 2025-11-10 | 08:00 ET | [8-K](/filings/0001104659-25-108840.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-108840 |
| 2025-10-30 | 07:15 ET | [8-K](/filings/0001104659-25-104009.md) | 8.01 Other events | 0001104659-25-104009 |
| 2025-10-14 | 07:00 ET | [8-K](/filings/0001104659-25-098992.md) | 8.01 Other events | 0001104659-25-098992 |
| 2025-09-15 | 08:30 ET | [8-K](/filings/0001104659-25-089773.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001104659-25-089773 |
| 2025-09-10 | 06:30 ET | [8-K](/filings/0001104659-25-088800.md) | 8.01 Other events | 0001104659-25-088800 |
| 2025-08-27 | 07:01 ET | [8-K](/filings/0001104659-25-083402.md) | 8.01 Other events | 0001104659-25-083402 |
| 2025-08-18 | 17:16 ET | [8-K](/filings/0001104659-25-079880.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-079880 |
| 2025-08-18 | 07:05 ET | [8-K](/filings/0001104659-25-079459.md) | 8.01 Other events | 0001104659-25-079459 |
| 2025-08-15 | 09:18 ET | [8-K](/filings/0001104659-25-079042.md) | 8.01 Other events | 0001104659-25-079042 |
| 2025-08-12 | 09:02 ET | [10-Q](/filings/0001558370-25-011158.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011158 |
| 2025-08-12 | 08:05 ET | [8-K](/filings/0001104659-25-076501.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076501 |
| 2025-08-11 | 17:00 ET | [8-K](/filings/0001104659-25-076214.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-076214 |
| 2025-08-11 | 07:30 ET | [8-K](/filings/0001104659-25-075915.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-075915 |
| 2025-08-06 | 07:19 ET | [8-K](/filings/0001104659-25-074514.md) | 8.01 Other events | 0001104659-25-074514 |
| 2025-08-01 | 07:12 ET | [8-K](/filings/0001104659-25-072900.md) | 8.01 Other events | 0001104659-25-072900 |
| 2025-07-21 | 07:15 ET | [8-K](/filings/0001104659-25-069149.md) | 8.01 Other events | 0001104659-25-069149 |
| 2025-07-15 | 08:00 ET | [8-K](/filings/0001104659-25-067951.md) | 8.01 Other events | 0001104659-25-067951 |
| 2025-05-27 | 07:00 ET | [8-K](/filings/0001104659-25-052704.md) | 8.01 Other events | 0001104659-25-052704 |
| 2025-05-12 | 09:00 ET | [10-Q](/filings/0001558370-25-007269.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007269 |
| 2025-05-12 | 07:15 ET | [8-K](/filings/0001104659-25-047013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-047013 |
| 2025-04-03 | 16:32 ET | [8-K](/filings/0001104659-25-031713.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-031713 |
| 2025-03-28 | 16:05 ET | [10-K](/filings/0001558370-25-003985.md) | Annual report, period 2024-12-31 | 0001558370-25-003985 |
| 2025-03-27 | 16:15 ET | [8-K](/filings/0001104659-25-028776.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-028776 |
| 2025-03-21 | 17:00 ET | [8-K](/filings/0001104659-25-026708.md) | 3.01 Delisting notice | 0001104659-25-026708 |
| 2025-03-21 | 07:00 ET | [8-K](/filings/0001104659-25-026388.md) | 8.01 Other events | 0001104659-25-026388 |
| 2025-03-04 | 16:30 ET | [8-K](/filings/0001104659-25-020349.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-020349 |

Page 1 of 5. [Older](/companies/btaiq/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:24 ET. No prices; not investment advice.